Exponent (NASDAQ:EXPO – Get Free Report) released its earnings results on Thursday. The business services provider reported $0.46 EPS for the quarter, topping the consensus estimate of $0.40 by $0.06, Zacks reports. Exponent had a net margin of 19.52% and a return on equity of 27.73%. During the same period in the previous year, the firm posted $0.41 earnings per share.
Exponent Trading Up 7.7 %
NASDAQ EXPO opened at $96.74 on Friday. The stock has a market capitalization of $4.91 billion, a price-to-earnings ratio of 46.28 and a beta of 0.71. The business’s 50 day moving average is $92.13 and its two-hundred day moving average is $100.83. Exponent has a 12-month low of $74.30 and a 12-month high of $115.75.
Exponent Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.24%. This is a positive change from Exponent’s previous quarterly dividend of $0.28. Exponent’s payout ratio is currently 54.11%.
Insider Activity
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- What Are Trending Stocks? Trending Stocks Explained
- Broadcom’s Bull Run: Time to Jump In?
- What is a support level?
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.